Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

Description

To conduct an unblinded pragmatic randomized controlled trial (pRCT) "Improvement of PPROM Management with Prophylactic Antimicrobial Therapy (iPROMPT)" of a seven-day course of ceftriaxone, clarithromycin, and metronidazole versus the current standard of care of a seven-day course of ampicillin/amoxicillin and azithromycin or erythromycin to prolong pregnancy and decrease adverse perinatal outcomes among hospitalized pregnant individuals undergoing expectant management of PPROM \<34 weeks.

Conditions

Preterm Premature Rupture of Membrane, Pregnancy, High Risk, Preterm Birth

Study Overview

Study Details

Study overview

To conduct an unblinded pragmatic randomized controlled trial (pRCT) "Improvement of PPROM Management with Prophylactic Antimicrobial Therapy (iPROMPT)" of a seven-day course of ceftriaxone, clarithromycin, and metronidazole versus the current standard of care of a seven-day course of ampicillin/amoxicillin and azithromycin or erythromycin to prolong pregnancy and decrease adverse perinatal outcomes among hospitalized pregnant individuals undergoing expectant management of PPROM \<34 weeks.

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

Condition
Preterm Premature Rupture of Membrane
Intervention / Treatment

-

Contacts and Locations

Columbus

The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus, Ohio, United States, 43210

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to

    Sexes Eligible for Study

    FEMALE

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    Ohio State University,

    Marissa Berry, MD, PRINCIPAL_INVESTIGATOR, Ohio State University

    Kartik K Venkatesh, MD, PhD, PRINCIPAL_INVESTIGATOR, Ohio State University

    Study Record Dates

    2025-12